Role of an anti-gastrin vaccine (PAS) alone and in combination with a PD-1 antibody on growth and metastases of gastric cancer

被引：0
|
作者：
Smith, Jill P.
Cao, Hong
Chen, Wenqiang
Mahmood, Kanwal
Phillips, Teresa
Sutton, Lynda Youngpeter
Cato, Allen
机构：
[1] Georgetown Univ, Dept Med, Washington, DC 20007 USA
[2] Georgetown Univ, Washington, DC 20007 USA
[3] Canc Adv Inc, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 04期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1200/JCO.2022.40.4_suppl.334
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
334
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1/PD-L axis
    Renata Duchnowska
    Rafał Pęksa
    Barbara Radecka
    Tomasz Mandat
    Tomasz Trojanowski
    Bożena Jarosz
    Bogumiła Czartoryska-Arłukowicz
    Wojciech P. Olszewski
    Waldemar Och
    Ewa Kalinka-Warzocha
    Wojciech Kozłowski
    Anna Kowalczyk
    Sherene Loi
    Wojciech Biernat
    Jacek Jassem
    Breast Cancer Research, 18
  • [22] Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1/PD-L axis
    Duchnowska, Renata
    Peksa, Rafal
    Radecka, Barbara
    Mandat, Tomasz
    Trojanowski, Tomasz
    Jarosz, Bozena
    Czartoryska-Arlukowicz, Bogumila
    Olszewski, Wojciech P.
    Och, Waldemar
    Kalinka-Warzocha, Ewa
    Kozlowski, Wojciech
    Kowalczyk, Anna
    Loi, Sherene
    Biernat, Wojciech
    Jassem, Jacek
    BREAST CANCER RESEARCH, 2016, 18
  • [23] Neoantigen personalized vaccine plus anti-PD-1 antibody in cancer patients
    Gonzalez-Cao, Maria
    Rosell, Rafael
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (24)
  • [24] Combination of Oral WT1 Cancer Vaccine and Anti-PD-1 Antibody Induced the Synergistic Anti-Tumor Effect in Mouse Prostate Cancer Model
    Kitagawa, Koichi
    Gonoi, Reina
    Saito, Hiroki
    Tatsumi, Maho
    Hashii, Yoshiko
    Katayama, Takane
    Shirakawa, Toshiro
    MOLECULAR THERAPY, 2017, 25 (05) : 156 - 156
  • [25] Revisiting anti-CTLA-4 antibodies in combination with PD-1 blockade for cancer immunotherapy
    Sznol, M.
    Melero, I.
    ANNALS OF ONCOLOGY, 2021, 32 (03) : 295 - 297
  • [26] Rationale of combination of anti-PD-1/PD-L1 antibody therapy and radiotherapy for cancer treatment
    Sato, Hiro
    Okonogi, Noriyuki
    Nakano, Takashi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (05) : 801 - 809
  • [27] Rationale of combination of anti-PD-1/PD-L1 antibody therapy and radiotherapy for cancer treatment
    Hiro Sato
    Noriyuki Okonogi
    Takashi Nakano
    International Journal of Clinical Oncology, 2020, 25 : 801 - 809
  • [28] Apatinib combined with PD-1 antibody for third-line or later treatment of advanced gastric cancer
    Cui, Qingli
    Mao, Yuefeng
    Wu, Daoyuan
    Hu, Yanhui
    Ma, Dongyang
    Zhang, LiHan
    Liu, Huaimin
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [29] Effective personalized neoantigen vaccine plus anti-PD-1 in a PD-1 blockade-resistant lung cancer patient
    Gao, Song
    Wang, Jiaqian
    Zhu, Zhongzheng
    Fang, Juemin
    Zhao, Yu
    Liu, Zhuqing
    Qin, Huanlong
    Wei, Yuquan
    Xu, Heng
    Dan, Xu
    Yang, Li
    Xu, Qing
    IMMUNOTHERAPY, 2023, 15 (02) : 57 - 70
  • [30] RATIONALE OF USING THE COMBINATION OF ANTI-PD-1 ANTIBODY AND ANTI-IL-8 ANTIBODY FOR THE PANCREATIC CANCER TREATMENT
    Li, P.
    Rozich, N.
    Wang, J.
    Gai, J.
    Wang, J.
    Xu, Y.
    Herbst, B.
    Yu, R.
    Muth, S.
    Niu, N.
    Li, K.
    Fune, V.
    Osipov, A.
    Wolfgang, C.
    Lei, M.
    Liang, T.
    Zheng, L.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A24 - A25
12345